Market revenue in 2024 | USD 1,113.8 million |
Market revenue in 2030 | USD 1,629.7 million |
Growth rate | 6.5% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 43.17% in 2024. Horizon Databook has segmented the Canada cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
Sudden Cardiac Arrest (SCA) is a leading cause of death in Canada, resulting in thousands of fatalities each year. According to the Heart and Stroke Foundation (HSF) of Canada, an estimated 60,000 residents experience SCA annually. The high incidence of SCA underscores the critical need for effective interventions & treatments to prevent mortality and improve patient outcomes.
SCA is a medical emergency that requires immediate intervention to restore normal heart rhythm and prevent irreversible damage or death. CRMDs, such as Implantable Cardioverter-Defibrillators (ICDs), are essential devices for delivering life-saving therapy, such as defibrillation, in the event of SCA. These factors are expected to support market growth in the forecast period.
Moreover, increasing government initiatives is one of the major factors that drive the market in the country. For instance, in May 2022, the government of Canada announced the funding of USD 5 million to support a new national research network that focuses on improving the treatment, diagnosis, prevention, and care of heart failure across the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into Canada cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account